中华皮肤科杂志 ›› 2022, Vol. 55 ›› Issue (10): 925-928.doi: 10.35541/cjd.20200496
荆可,李锁,冯素英
收稿日期:
2020-05-21
修回日期:
2021-07-15
发布日期:
2022-10-08
通讯作者:
冯素英
E-mail:fengsy@pumcderm.cams.cn
基金资助:
Jing Ke, Li Suo, Feng Suying
Received:
2020-05-21
Revised:
2021-07-15
Published:
2022-10-08
Contact:
Feng Suying
E-mail:fengsy@pumcderm.cams.cn
Supported by:
摘要: 【摘要】 线状IgA大疱性皮病(LABD)是一种少见的自身免疫性表皮下水疱病。目前针对LABD的研究尚不完善,多为病例报道。本文综述LABD的病因和发病机制、临床及组织病理表现、诊断及治疗等方面的近期研究。
荆可 李锁 冯素英. 线状IgA大疱性皮病的研究进展[J]. 中华皮肤科杂志, 2022,55(10):925-928. doi:10.35541/cjd.20200496
Jing Ke, Li Suo, Feng Suying. Linear IgA bullous dermatosis[J]. Chinese Journal of Dermatology, 2022, 55(10): 925-928.doi:10.35541/cjd.20200496
[1] | Lammer J, Hein R, Roenneberg S, et al. Drug⁃induced linear IgA bullous dermatosis: a case report and review of the literature[J]. Acta Derm Venereol, 2019,99(6):508⁃515. doi: 10.2340/00015 555⁃3154. |
[2] | Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous dermatosis[J]. Clin Dermatol, 2012,30(1):38⁃50. doi: 10.1016/j.clindermatol.2011.03.008. |
[3] | Tsuchisaka A, Ohara K, Ishii N, et al. Type VII collagen is the major autoantigen for sublamina densa⁃type linear IgA bullous dermatosis[J]. J Invest Dermatol, 2015,135(2):626⁃629. doi: 10.1038/jid.2014.381. |
[4] | Cozzani E, Di Zenzo G, Gasparini G, et al. Autoantibody profile of a cohort of 54 Italian patients with linear IgA bullous dermatosis: LAD⁃1 denoted as a major auto⁃antigen of the lamina lucida subtype[J]. Acta Derm Venereol, 2020,100(4):adv00070. doi: 10.2340/00015555⁃3415. |
[5] | Edwards G, Diercks G, Seelen M, et al. Complement activation in autoimmune bullous dermatoses: a comprehensive review[J]. Front Immunol, 2019,10:1477. doi: 10.3389/fimmu.2019.01477. |
[6] | Hoffmann J, Hadaschik E, Enk A, et al. Linear IgA bullous dermatosis secondary to infliximab therapy in a patient with ulcerative colitis[J]. Dermatology, 2015,231(2):112⁃115. doi: 10.1159/000431172. |
[7] | Riemenschneider K, Diiorio DA, Zic JA, et al. Drug⁃induced linear IgA bullous dermatosis in a patient with a vancomycin⁃impregnated cement spacer[J]. Cutis, 2018,101(4):293⁃296. |
[8] | Tadiotto Cicogna G, Ferranti M, Vaccari D, et al. Topical imiquimod⁃induced linear IgA bullous dermatosis[J]. BMJ Case Rep, 2019,12(7):e230037. doi: 10.1136/bcr⁃2019⁃230037. |
[9] | Tiger JB, Rush JT, Barton DT, et al. Urticarial linear IgA bullous dermatosis (LABD) as a presenting sign of chronic lymphocytic leukemia (CLL)[J]. JAAD Case Rep, 2015,1(6):412⁃414. doi: 10.1016/j.jdcr.2015.10.001. |
[10] | Colmant C, Camboni A, Dekeuleneer V, et al. Linear IgA dermatosis in association with angioimmunoblastic T⁃cell lymphoma infiltrating the skin: a case report with literature review[J]. J Cutan Pathol, 2020,47(3):251⁃256. doi: 10.1111/cup.13576. |
[11] | Kanda N, Nakadaira N, Otsuka Y, et al. Linear IgA bullous dermatosis associated with ulcerative colitis: a case report and literature review[J]. Australas J Dermatol, 2020,61(1):e82⁃e86. doi: 10.1111/ajd.13121. |
[12] | Malipatel R, Gnanapriya V, Manocha A, et al. Systemic lupus erythematosus with linear IgA bullous dermatosis and renal vascular lesions: an extremely rare association[J]. Indian J Nephrol, 2018,28(6):465⁃467. doi: 10.4103/ijn.IJN_200_17. |
[13] | Tieppo Francio V, Towery C, Davani S, et al. Previously misdiagnosed linear IgA dermatosis resolved with dapsone[J]. BMJ Case Rep, 2018,2018:bcr2017220623. doi: 10.1136/bcr⁃2017⁃220623. |
[14] | Ikkaku N, Tateishi C, Oda Y, et al. Linear immunoglobulin A bullous dermatosis developing during late pregnancy[J]. J Dermatol, 2017,44(3):e44⁃e45. doi: 10.1111/1346⁃8138.13475. |
[15] | 陈吉辉, 苟辉, 张敏, 等. 妊娠期并发成人型线状IgA大疱性皮病1例报告[J]. 四川大学学报(医学版), 2019,50(2):288. |
[16] | Shetty VM, Pai SB, Rao R. Linear IgA bullous dermatosis presenting as chronic prurigo: unveiling of the diagnosis by serrated pattern analysis[J]. Int J Dermatol, 2018,57(11):e147⁃e149. doi: 10.1111/ijd.14253. |
[17] | Vives Ricoma E, El Uali Abeida M, Viso Soriano MJ, et al. Linear IgA bullous dermatosis with laryngeal involvement[J]. Acta Otorrinolaringol Esp, 2020,71(3):190⁃192. doi: 10.1016/j.otorri.2019.05.006. |
[18] | Shah S, Mohr B, Parekh P. Linear IgA bullous dermatosis mimicking oral lichen planus[J]. Proc (Bayl Univ Med Cent), 2017,30(3):360⁃361. doi: 10.1080/08998280.2017.11929649. |
[19] | Wang H, Wang X, Yang B, et al. Image gallery: onychomadesis in linear IgA bullous dermatosis[J]. Br J Dermatol, 2020,182(5):e160. doi: 10.1111/bjd.18744. |
[20] | Choudhry SZ, Kashat M, Lim HW. Vancomycin⁃induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon[J]. Int J Dermatol, 2015,54(11):1211⁃1213. doi: 10.1111/ijd.12944. |
[21] | Mesa⁃Álvarez L, Peón Currás G, Flórez Á. Widespread erythematous and bullous plaques associated with nasolabial fold ulceration: answer[J]. Am J Dermatopathol, 2019,41(3):237⁃238. doi: 10.1097/DAD.0000000000001051. |
[22] | Nguyen JK, Koshelev MV, Gill BJ, et al. A toxic epidermal necrolysis⁃like presentation of linear IgA bullous dermatosis treated with dapsone[J]. Dermatol Online J, 2017,23(8):13030/qt4443157h. |
[23] | Helmandollar KJ, Hoverson KR, Falkner RC, et al. Diffuse vesiculobullous eruption with systemic findings[J]. Dermatol Online J, 2018,24(5):13030/qt09m1x0c1. |
[24] | Fulton E, Jan F, Zimarowski MJ. Flame figures in linear IgA bullous dermatosis: a novel histopathologic finding[J]. Dermatol Online J, 2017,23(11):13030/qt1qs7m39f. |
[25] | Díaz MS, Morita L, Ferrari B, et al. Linear IgA bullous dermatosis: a series of 17 cases[J]. Actas Dermosifiliogr, 2019,110(8):673⁃680. doi: 10.1016/j.ad.2018.06.017. |
[26] | Ohata C, Ishii N, Koga H, et al. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence[J]. Br J Dermatol, 2017,177(1):152⁃157. doi: 10.1111/bjd.15232. |
[27] | Shan XF, Zhang FR, Tian HQ, et al. A case of linear IgA dermatosis successfully treated with tetracycline and niacinamide[J]. Int J Dermatol, 2016,55(4):e216⁃e217. doi: 10.1111/ijd. 12524. |
[28] | Cui YX, Yang BQ, Zhou GZ, et al. Childhood linear IgA bullous dermatosis successfully treated with oral nicotinamide[J]. Clin Exp Dermatol, 2016,41(7):816⁃818. doi: 10.1111/ced.12892. |
[29] | Kaya İslamoğlu ZG, Akyürek FT. A case of recalcitrant linear IgA bullous dermatosis: successfully treated with rituximab[J]. Dermatol Ther, 2019,32(3):e12911. doi: 10.1111/dth.12911. |
[30] | Lamberts A, Euverman HI, Terra JB, et al. Effectiveness and safety of rituximab in recalcitrant pemphigoid diseases[J]. Front Immunol, 2018,9:248. doi: 10.3389/fimmu.2018.00248. |
[31] | Maalouf NS, Hanna D. Linear IgA bullous dermatosis successfully treated with omalizumab: a case report[J]. JAAD Case Rep, 2019,5(11):966⁃969. doi: 10.1016/j.jdcr.2019.08.019. |
[32] | Yamada S, Makino T, Jinnin M, et al. Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab[J]. Dermatology, 2013,227(4):295⁃298. doi: 10.1159/000355354. |
[33] | Legendre L, Maza A, Almalki A, et al. Botulinum toxin a: an effective treatment for linear immunoglobulin A bullous dermatosis located in the axillae[J]. Acta Derm Venereol, 2016,96(1):122⁃123. doi: 10.2340/00015555⁃2178. |
[1] | 魏瑾 臧东杰 曾三武 蒋靖 伦文辉. Dowling-Degos病1家系KRT5基因新突变分析[J]. 中华皮肤科杂志, 2022, 55(8): 703-705. |
[2] | 樊碧娆 陈喜雪 王明悦. [开放获取] 米诺环素单药或联合小剂量糖皮质激素治疗红斑型天疱疮15例和疱疹样天疱疮9例疗效和安全性回顾分析[J]. 中华皮肤科杂志, 2022, 55(8): 676-681. |
[3] | 曹淼 崇杉 胡新媛 朱学骏 王明悦. 副肿瘤性天疱疮患者原发肿瘤切除后皮肤黏膜感染及管理分析[J]. 中华皮肤科杂志, 2022, 55(8): 669-675. |
[4] | 晋亮 刘玲. 部分遗传性皮肤病的治疗进展[J]. 中华皮肤科杂志, 2022, 55(8): 735-739. |
[5] | 徐哲. 对遗传性皮肤病的一些思考[J]. 中华皮肤科杂志, 2022, 55(8): 651-652. |
[6] | 王媛 李志量 李锁 荆可 孙超 梁桂熔 张寒梅 冯素英. 抗p200类天疱疮7例临床及免疫血清学特征分析[J]. 中华皮肤科杂志, 2022, 55(7): 557-561. |
[7] | 高子蕊 赵培 窦沅青 刘萍 张建中. 度普利尤单抗治疗成人结节性痒疹的疗效与安全性观察[J]. 中华皮肤科杂志, 2022, 55(7): 562-565. |
[8] | 王玲艳 潘靖 苗钢 常晓丹 金秋子 郭宁宁 张佳钰. 对生物制剂治疗抵抗的银屑病患者皮损部位分析[J]. 中华皮肤科杂志, 2022, 55(7): 583-587. |
[9] | 吕莎 王爽 武寒飞 张明瑞 胡馨 李福秋. 孢子丝菌病研究进展[J]. 中华皮肤科杂志, 2022, 55(7): 629-632. |
[10] | 张宁 李舒 李敬. 免疫检查点抑制剂和靶向药物辅助治疗可切除黑素瘤疗效的网状Meta分析[J]. 中华皮肤科杂志, 2022, 55(7): 603-609. |
[11] | 中华医学会皮肤性病学分会特应性皮炎研究中心 中华医学会皮肤性病学分会儿童学组. 【开放获取】度普利尤单抗治疗特应性皮炎专家共识[J]. 中华皮肤科杂志, 2022, 55(6): 465-470. |
[12] | 中国医师协会皮肤科医师分会自身免疫病专业委员会 . 【开放获取】环孢素治疗免疫相关性皮肤病专家建议[J]. 中华皮肤科杂志, 2022, 55(6): 471-479. |
[13] | 赵柳琦 陈妍 陈丹阳 樊碧娆 王瑞 尚盼盼 陈喜雪 朱学骏 王明悦. 【开放获取】度普利尤单抗治疗大疱性类天疱疮21例的疗效及安全性回顾分析[J]. 中华皮肤科杂志, 2022, 55(6): 480-485. |
[14] | 黄馨 陈筱昀 李亚萍 梁兴堃 张桂英 周英 湛意 罗帅寒天 廖洁月 肖嵘 龙海. 度普利尤单抗治疗123例特应性皮炎的疗效及安全性分析[J]. 中华皮肤科杂志, 2022, 55(6): 486-493. |
[15] | 温广东 冒丹丹 张原媛 窦沅青 赵培 吴晨雨 张建中. 【开放获取】度普利尤单抗治疗泛发性苔藓状淀粉样变1例国内首报[J]. 中华皮肤科杂志, 2022, 55(6): 508-510. |
|